Simultaneous Measurement of β-Amyloid(1–42), Total Tau, and Phosphorylated Tau (Thr181) in Cerebrospinal Fluid by the xMAP Technology
Annika Olsson(Sahlgrenska University Hospital), Kaj Blennow(Sahlgrenska University Hospital), Hugo Vanderstichele(ADx NeuroSciences), Geert De Meyer(Fujirebio (Belgium)), Eugeen Vanmechelen(ADx NeuroSciences), Anders Wallin(University of Gothenburg), Björn Holmberg(Sahlgrenska University Hospital), Niels Andreasen, Lars Rosengren(Sahlgrenska University Hospital)
Cited by 441
Related Papers
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
|The Lancet Neurology|2020|1.3k
Vascular dysfunction—The disregarded partner of Alzheimer's disease
|Alzheimer s & Dementia|2019|721